A nationwide epidemiological investigation analyzing the electronic patient records of 905,553 dogs attended across 887 primary veterinary clinics in the United Kingdom confirmed 2,105 cases of hypothyroidism during 2016, establishing an annual period prevalence of 0.23 percent with a 95 percent confidence interval spanning 0.22 to 0.24 percent. Among this cohort, 359 dogs received their initial diagnosis during the 2016 calendar year, generating an annual incidence risk of 0.04 percent with a 95 percent confidence interval of 0.04 to 0.04 percent, while the remaining 1,746 dogs represented pre-existing cases diagnosed in preceding years. Derived from the VetCompass Programme, these findings provide the first large-scale empirical assessment of hypothyroidism frequency and associated risk profiles drawn entirely from general veterinary practice rather than specialized secondary or tertiary referral centers. By demonstrating that 83 percent of prevalent animals had been diagnosed prior to 2016, the data indicate that affected dogs frequently survive for extended periods following identification, emphasizing that prevalence metrics reflect populations living with long-term managed hormone deficiency rather than acute onset.
Hypothyroidism represents one of the most frequently identified endocrine disorders in domestic canines, arising from an underlying physiological deficiency in circulating thyroid hormones, specifically triiodothyronine (T3) and thyroxine (T4). In the vast majority of clinical cases, the disease manifests as primary acquired hypothyroidism brought on by irreversible, progressive destruction of the thyroid gland tissue. Histopathological examinations establish that two distinct pathological mechanisms account for almost all primary cases in dogs: autoimmune lymphocytic thyroiditis and non-inflammatory idiopathic follicular atrophy, with scientific consensus pointing toward an approximate one-to-one ratio between these two underlying origins. In cases characterized by lymphocytic thyroiditis, circulating autoantibodies directed against thyroglobulin (TgAA) represent the most frequent serological marker, although TgAA prevalence fluctuates substantially between different canine breeds. The clinical consequence of insufficient thyroid hormone production encompasses wide-ranging dermatological and metabolic abnormalities that meaningfully reduce patient quality of life and, in exceedingly rare and severe presentations, can culminate in life-threatening myxedema coma.
Historically, scientific literature addressing canine hypothyroidism derived predominantly from teaching hospitals and tertiary referral facilities, which published estimated prevalence rates ranging from 0.2 to 0.8 percent of patient caseloads. However, because hypothyroidism is routinely diagnosed, treated, and monitored entirely within the primary veterinary setting, referral cohorts introduced substantial selection bias and lacked representative demographic power for general canine populations. To overcome these limitations, the research team designed a comprehensive cohort framework utilizing de-identified electronic records contributed by primary veterinary facilities across the UK. Prior to sampling, power calculations demonstrated that a minimum sample size of 52,235 dogs was necessary to estimate prevalence for a condition occurring in approximately 0.35 percent of dogs with an acceptable margin of error of 0.05 percent at a 95 percent confidence level from an estimated national UK canine population of 8 million animals. Ethical approval for the study protocol was granted by the Royal Veterinary College Social Sciences Research Ethical Review Board under reference SR2018-1652.
Case identification within the database followed a rigorous two-step screening protocol applied to animals meeting the inclusion standard of at least one electronic record in 2016, or at least one record in both 2015 and 2017. In the initial automated screening phase, clinical free-text narratives and pharmaceutical prescription fields up to December 31, 2016, were queried for terms including diagnostic shorthand, misspellings, hormone assays, and thyroid medications such as levothyroxine, soloxine, thyforon, or canitroid. This text-mining search yielded 22,401 candidate records, which were subsequently randomized and subjected to individual manual review by researchers. To qualify as a confirmed case, an animal required explicit clinical evidence supporting a final diagnosis of hypothyroidism rendered by a veterinary surgeon registered with the Royal College of Veterinary Surgeons, or documented prescription of levothyroxine before December 31, 2016, specifically intended to treat hypothyroidism. The investigation intentionally refrained from imposing retrospective laboratory cutoff thresholds or external diagnostic consensus criteria, preserving the authentic clinical decision-making diagnostic protocols typical of frontline primary practice.
Demographic variables extracted from patient files were mapped to standardized naming architectures developed from the VeNom Coding list, categorizing animals into purebreds, designer crossbreeds possessing contrived compound names, and general crossbred dogs. Further structural classifications grouped dogs by adult bodyweight recorded after 18 months, bodyweight relative to breed-sex averages where at least 100 individuals were available, skull conformation categories encompassing dolichocephalic, mesocephalic, and brachycephalic profiles, and UK Kennel Club recognized breed divisions. Statistical evaluations performed in Stata Version 16 implemented binary logistic regression models to compute univariable associations with hypothyroidism diagnosis. Candidate variables showing liberal associations at a significance threshold of P < 0.2 were progressed into multivariable modeling utilizing manual backwards stepwise elimination. Because specific structural and breed-group indicators correlated directly with breed assignment, these variables were subsequently evaluated by replacing the breed variable individually within the finalized multivariable framework, while practice-level clustering was accounted for by modeling attending veterinary clinics as a random effect.
The demographic distribution across the cohort highlighted clear differences between dogs diagnosed with hypothyroidism and their unaffected counterparts. Purebred animals accounted for 82.65 percent of hypothyroid cases compared to 72.56 percent of non-cases, while neutered individuals constituted 69.94 percent of hypothyroid dogs compared to 45.21 percent among non-cases. Female dogs represented 50.31 percent of diagnosed cases and 47.89 percent of non-cases. Hypothyroid dogs displayed a median adult bodyweight of 25.63 kg with an interquartile range of 15.16 to 35.07 kg, whereas non-cases exhibited a substantially lighter median adult bodyweight of 13.92 kg with an interquartile range of 8.18 to 25.00 kg. For incident cases first diagnosed during 2016, the median age at diagnosis was 7.65 years with an interquartile range of 5.65 to 9.89 years. The breeds most frequently represented within the absolute case count were crossbred dogs with 332 cases, boxers with 184 cases, Labrador retrievers with 182 cases, and English cocker spaniels with 122 cases.
Multivariable logistic regression analysis revealed that breed stood as an exceptionally powerful independent risk factor, identifying 24 distinct purebred breeds with statistically significant increased odds of receiving a hypothyroidism diagnosis when compared against general crossbred dogs. The standard Doberman pinscher exhibited the highest vulnerability in the entire study, displaying 17.02 times the odds of hypothyroidism seen in crossbreds, with a 95 percent confidence interval of 12.80 to 22.64. The Tibetan terrier demonstrated the second-highest odds ratio at 11.25 with a 95 percent confidence interval of 8.27 to 15.32, alongside the single highest one-year period prevalence across all studied breeds at 2.78 percent. Boxers also showed marked predisposition, with an odds ratio of 10.44 and a confidence interval of 8.66 to 12.58, followed closely by the Alaskan malamute at an odds ratio of 9.71 with a confidence interval of 6.11 to 15.42. All four top-tier breeds demonstrated associations reaching statistical significance at P < 0.001.
In contrast to the predisposed groups, the multivariable model identified nine specific breeds displaying significantly reduced odds of hypothyroidism diagnosis relative to crossbreds, documenting evidence of breed-level protection. The lowest odds were recorded in the pug, which exhibited an odds ratio of 0.29 with a 95 percent confidence interval of 0.09 to 0.89 and a P value of 0.031. Other significantly protected breeds included the Yorkshire terrier with an odds ratio of 0.38 and a confidence interval of 0.24 to 0.59, the Shih-tzu with an odds ratio of 0.38 and a confidence interval of 0.23 to 0.64, and the Jack Russell terrier with an odds ratio of 0.40 and a confidence interval of 0.29 to 0.54, all achieving P < 0.001. Intriguingly, two widely registered designer hybrid populations, the cavachon and the cavapoo, recorded zero instances of diagnosed hypothyroidism across the entire 2016 study year, despite both designer types numbering more than 3,500 individual dogs within the analyzed patient cohort.
Patient age and relative bodyweight emerged as critical determinants in the final multivariable regression model. Dogs maintaining an adult bodyweight at or above the mean established for their specific breed and sex demonstrated 2.06 times the odds of receiving a diagnosis compared to dogs weighing below their respective breed-sex average, with a 95 percent confidence interval of 1.87 to 2.29 at P < 0.001. The likelihood of living with diagnosed hypothyroidism climbed progressively across successive age brackets; dogs aged 11 to under 13 years exhibited an odds ratio of 4.54 with a 95 percent confidence interval of 3.86 to 5.33 compared against the reference category of dogs aged 5 to under 7 years, while the oldest group exceeding 13 years showed the greatest overall odds. Because hypothyroidism rarely truncates life expectancy when appropriately managed, these elevated odds among older dogs reflect the cumulative persistence of long-term diagnosed cases across the canine lifespan rather than elevated de novo disease acquisition in late senescence.
Neutering and commercial pet insurance coverage both demonstrated substantial associations with hypothyroidism status in the adjusted multivariable model. Neutered female dogs displayed 1.46 times higher odds of diagnosis compared to entire females, with a 95 percent confidence interval of 1.26 to 1.69, while neutered males exhibited 1.31 times higher odds with a confidence interval of 1.13 to 1.52. Because confidence intervals overlapped across sexes within intact and neutered statuses, biological sex itself showed no independent predisposition. Insured canines displayed 2.27 times higher odds of being diagnosed with hypothyroidism compared to uninsured animals, supported by a 95 percent confidence interval of 2.05 to 2.52. The authors highlighted that insurance coverage often mitigates financial constraints surrounding diagnostic testing, suggesting that unmanaged or undiagnosed hypothyroidism may be disproportionately present among uninsured pets. Incorporating attending clinic as a random effect revealed a rho value of 0.06, indicating that 6 percent of total diagnostic variability stemmed from differences in clinical expertise, equipment, and protocols between veterinary practices.
Evaluating structural and lineage traits through variable substitution provided further insights into underlying patterns of disorder expression. Purebred dogs overall exhibited 1.49 times higher odds of hypothyroidism diagnosis relative to crossbred dogs, with a 95 percent confidence interval of 1.32 to 1.68 at P < 0.001, an elevation that persisted independently of insurance and neuter variables. Across UK Kennel Club categories, the Working, Gundog, Hound, Pastoral, and Utility groups displayed significantly elevated odds, whereas the Terrier and Toy groups exhibited decreased odds compared to non-recognized breeds. In skull conformation models, dolichocephalic dogs had 1.35 times the odds and brachycephalic dogs had 1.15 times the odds of hypothyroidism relative to mesocephalic breeds. When adult bodyweight was modeled directly in place of breed variables, increasing weight correlated with steadily rising odds of diagnosis. The biological mechanisms driving these disparities may relate to genetic architecture, such as major histocompatibility complex DLA class II haplotypes previously identified in Doberman pinschers, or health-protective hybrid vigor operating within genetically diverse crossbreds.
The study authors acknowledged important methodological constraints inherent in epidemiological investigations relying upon secondary clinical records, including variable clinical notetaking standards, incomplete data fields, and the absence of standardized diagnostic consensus protocols across independent practices. Furthermore, because body condition scoring was recorded inconsistently across clinics, the researchers could not differentiate obese dogs from heavily muscled or larger-framed individuals, preventing definitive causal conclusions regarding whether elevated bodyweight directly precipitated thyroid failure or resulted from metabolic slowing prior to diagnosis. The cohort structure also assessed prevalent cases alongside incident events, representing the odds of living with a diagnosis rather than acquiring the condition de novo. Nonetheless, by analyzing over 900,000 animals within everyday practice settings, this investigation provides realistic benchmarks for apparent primary care prevalence, illuminates novel protected breeds to guide genetic investigations, and offers evidence-based diagnostic awareness for clinicians managing suspected canine endocrinopathies.
Subject of Research: Epidemiology and demographic risk factors of canine hypothyroidism in primary veterinary care
Article Title: Frequency, breed predispositions and other demographic risk factors for diagnosis of hypothyroidism in dogs under primary veterinary care in the UK
Article References: O’Neill, D. G., Khoo, J. S. P., Brodbelt, D. C., Church, D. B., Pegram, C., & Geddes, R. F. (2022). Frequency, breed predispositions and other demographic risk factors for diagnosis of hypothyroidism in dogs under primary veterinary care in the UK. Canine Medicine and Genetics, 9(1), Article 11. https://doi.org/10.1186/s40575-022-00123-8
Image Credits: AI Generated
DOI: 10.1186/s40575-022-00123-8
Keywords: canine hypothyroidism, VetCompass, primary veterinary care, epidemiology, Doberman pinscher, Tibetan terrier, boxer, breed predisposition, endocrinopathy, thyroxine, triiodothyronine, canine genetics, pet insurance, veterinary medicine, prevalence, incidence risk
News Source: William Thompson. (November 13, 2026). UK Primary Care Dog Study Identifies Major Breed Hypothyroidism Risks. Scienmag.
